Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Liver Cancer

 

TheraSphere for Inoperable Liver Cancer (20111617)
A Phase III Clinical Trial of Intra-arterial TheraSphere in the Treatment of Patient with Unresectable Hepatocellular Carcinoma (HCC)

Investigator: William Harris;   Conditions: Gastrointestinal Cancer; Liver Cancer; Solid Tumors;    Status: Recruiting;   Study ID: NCT01556490

Lenvatinib (E7080) Vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma (20131240)
A Multicenter, Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular Carcinoma

Investigator: William Harris;   Conditions: Hepatocellular Carcinoma;    Status: Recruiting;   Study ID: NCT01761266